Email This Release
BioReliance Corporation Announces Agreement with Barr Pharmaceuticals to Supply Bulk Virus for the Manufacture of Adenovirus Vaccine for the U.S. Department of Defense
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
